Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Osteoporosis Drugs Market, by Route of Administration
1.4.2 Europe Osteoporosis Drugs Market, by Drug Class
1.4.3 Europe Osteoporosis Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Osteoporosis Drugs Market by Route of Administration
3.1 Europe Oral Market by Country
3.2 Europe Injectable Market by Country
3.3 Europe Other Route of Administration Market by Country
Chapter 4. Europe Osteoporosis Drugs Market by Drug Class
4.1 Europe Bisphosphonates Market by Country
4.2 Europe Rank Ligand Inhibitors Market by Country
4.3 Europe Parathyroid Hormone Therapy Market by Country
4.4 Europe Calcitonin Market by Country
4.5 Europe Other Drug Class Market by Country
Chapter 5. Europe Osteoporosis Drugs Market by Country
5.1 Germany Osteoporosis Drugs Market
5.1.1 Germany Osteoporosis Drugs Market by Route of Administration
5.1.2 Germany Osteoporosis Drugs Market by Drug Class
5.2 UK Osteoporosis Drugs Market
5.2.1 UK Osteoporosis Drugs Market by Route of Administration
5.2.2 UK Osteoporosis Drugs Market by Drug Class
5.3 France Osteoporosis Drugs Market
5.3.1 France Osteoporosis Drugs Market by Route of Administration
5.3.2 France Osteoporosis Drugs Market by Drug Class
5.4 Russia Osteoporosis Drugs Market
5.4.1 Russia Osteoporosis Drugs Market by Route of Administration
5.4.2 Russia Osteoporosis Drugs Market by Drug Class
5.5 Spain Osteoporosis Drugs Market
5.5.1 Spain Osteoporosis Drugs Market by Route of Administration
5.5.2 Spain Osteoporosis Drugs Market by Drug Class
5.6 Italy Osteoporosis Drugs Market
5.6.1 Italy Osteoporosis Drugs Market by Route of Administration
5.6.2 Italy Osteoporosis Drugs Market by Drug Class
5.7 Rest of Europe Osteoporosis Drugs Market
5.7.1 Rest of Europe Osteoporosis Drugs Market by Route of Administration
5.7.2 Rest of Europe Osteoporosis Drugs Market by Drug Class
Chapter 6. Company Profiles
6.1 Amgen, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expense
6.1.4 Recent strategies and developments:
6.1.4.1 Partnerships, Collaborations, and Agreements:
6.1.4.2 Approvals:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 GlaxoSmithKline PLC (GSK)
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Merck & Co., Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Novartis AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Recent strategies and developments:
6.5.4.1 Partnerships, Collaborations, and Agreements:
6.6 Pfizer, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Sun Pharmaceutical Industries Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expenses
6.9 Allergan PLC
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.1 Eli Lilly and Company
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expense



List of Tables


TABLE 1 EUROPE OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 3 EUROPE OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 4 EUROPE OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 5 EUROPE ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 EUROPE ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 EUROPE INJECTABLE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 EUROPE INJECTABLE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 EUROPE OTHER ROUTE OF ADMINISTRATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE OTHER ROUTE OF ADMINISTRATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 12 EUROPE OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 13 EUROPE BISPHOSPHONATES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE BISPHOSPHONATES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE RANK LIGAND INHIBITORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE RANK LIGAND INHIBITORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE PARATHYROID HORMONE THERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE PARATHYROID HORMONE THERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE CALCITONIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 EUROPE CALCITONIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 EUROPE OTHER DRUG CLASS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 EUROPE OTHER DRUG CLASS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 EUROPE OSTEOPOROSIS DRUGS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 EUROPE OSTEOPOROSIS DRUGS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 GERMANY OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 26 GERMANY OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 27 GERMANY OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 28 GERMANY OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 29 GERMANY OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 30 GERMANY OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 31 UK OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 32 UK OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 33 UK OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 34 UK OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 35 UK OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 36 UK OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 37 FRANCE OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 38 FRANCE OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 39 FRANCE OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 40 FRANCE OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 41 FRANCE OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 42 FRANCE OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 43 RUSSIA OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 44 RUSSIA OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 45 RUSSIA OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 46 RUSSIA OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 47 RUSSIA OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 48 RUSSIA OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 49 SPAIN OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 50 SPAIN OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 51 SPAIN OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 52 SPAIN OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 53 SPAIN OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 54 SPAIN OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 55 ITALY OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 56 ITALY OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 57 ITALY OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 58 ITALY OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 59 ITALY OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 60 ITALY OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 61 REST OF EUROPE OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 62 REST OF EUROPE OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 63 REST OF EUROPE OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 64 REST OF EUROPE OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 65 REST OF EUROPE OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 66 REST OF EUROPE OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 67 KEY INFORMATION – AMGEN, INC.
TABLE 68 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 69 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 70 KEY INFORMATION - MERCK & CO., INC.
TABLE 71 KEY INFORMATION – NOVARTIS AG
TABLE 72 KEY INFORMATION – PFIZER, INC.
TABLE 73 KEY INFORMATION – SUN PHARMACEUTICAL INDUSTRIES LTD.
TABLE 74 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 75 KEY INFORMATION – ALLERGAN PLC
TABLE 76 KEY INFORMATION – ELI LILLY AND COMPANY

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH